Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
ED.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BU.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.2.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BM.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBENYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BE.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.12NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.14NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.3.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.29NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BQ.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.32NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.5.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CK.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JM.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-17480.9Singapore
XBB.1.22.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GS.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.24NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HK.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCFNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XCFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.32NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CH.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GK.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.21NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.2.3.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.36NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FL.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.108NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.1.5.108NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.104NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used